tiprankstipranks
Bausch Health Companies (MX:BHCN)
:BHCN
Mexico Market
BHCN
Bausch Health Companies
RESEARCH TOOLSreports

Bausch Health Companies (BHCN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

BHCN Analyst Ratings

Hold
2Ratings
Hold
0 Buy
2 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Bausch
Health Companies
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BHCN Stock 12 Month Forecast

Average Price Target

$138.78
▲(67.21% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Bausch Health Companies in the last 3 months. The average price target is $138.78 with a high forecast of $156.13 and a low forecast of $121.43. The average price target represents a 67.21% change from the last price of $83.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"82":"$82","157":"$157","100.75":"$100.8","119.5":"$119.5","138.25":"$138.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":156.12802496999998,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$156.13</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":138.78046664,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$138.78</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":121.43290830999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$121.43</span>\n  </div></div>","useHTML":true}}],"tickPositions":[82,100.75,119.5,138.25,157],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,83,88.62523269,94.25046538,99.87569807,105.50093075999999,111.12616344999999,116.75139614,122.37662882999999,128.00186151999998,133.62709421,139.25232689999999,144.87755958999998,150.50279228,{"y":156.12802496999998,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,83,87.29080512615384,91.58161025230768,95.87241537846154,100.16322050461538,104.45402563076922,108.74483075692308,113.03563588307692,117.32644100923076,121.6172461353846,125.90805126153845,130.1988563876923,134.48966151384616,{"y":138.78046664,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,83,85.9563775623077,88.91275512461539,91.86913268692308,94.82551024923076,97.78188781153845,100.73826537384615,103.69464293615384,106.65102049846153,109.60739806076921,112.5637756230769,115.5201531853846,118.4765307476923,{"y":121.43290830999999,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":123.57,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":152,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":125,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":130,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":130,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":130,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":130,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":130,"date":1772323200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":130,"date":1775001600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":130,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":130,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":85.44,"date":1782864000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":83,"date":1785542400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$156.13Average Price Target$138.78Lowest Price Target$121.43
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on MX:BHCN
Douglas Miehm
RBC Capital
RBC Capital
$156.13
Hold
88.11%
Upside
Reiterated
07/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (NASDAQ: ALNY), Ultragenyx Pharmaceutical (NASDAQ: RARE) and Bausch Health Companies (NYSE: BHC)
Barclays Analyst forecast on MX:BHCN
Glen Santangelo
Barclays
Barclays
$121.43
Hold
46.30%
Upside
Assigned
06/03/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (NASDAQ: ABVX), Bausch Health Companies (NYSE: BHC) and Healthequity (NASDAQ: HQY)
Truist Financial Analyst forecast on MX:BHCN
Les Sulewski
Truist Financial
Truist Financial
―
Hold
―
Reiterated
05/01/26
Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (NYSE: BHC), Irhythm Technologies (NASDAQ: IRTC) and Bicycle Therapeutics (NASDAQ: BCYC)
Evercore ISI Analyst forecast on MX:BHCN
Umer Raffat
Evercore ISI
Evercore ISI
―
Hold
―
Reiterated
04/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (NYSE: TDOC), Bausch Health Companies (NYSE: BHC) and AbbVie (NYSE: ABBV)
TD Cowen Analyst forecast on MX:BHCN
Michael Nedelcovych
TD Cowen
TD Cowen
$121.43
Hold
46.30%
Upside
Reiterated
04/30/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Evolus (NASDAQ: EOLS) and Bausch Health Companies (NYSE: BHC)
Bank of America Securities Analyst forecast on MX:BHCN
Jason Gerberry
Bank of America Securities
Bank of America Securities
$86.74
Sell
4.50%
Upside
Reiterated
02/18/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (NYSE: MDT), Bausch Health Companies (NYSE: BHC) and Insulet (NASDAQ: PODD)
Raymond James Analyst forecast on MX:BHCN
Michael W. Freeman
Raymond James
Raymond James
$138.78
Hold
67.21%
Upside
Reiterated
08/05/25
Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (NYSE: BHC) and IDEAYA Biosciences (NASDAQ: IDYA)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on MX:BHCN
Douglas Miehm
RBC Capital
RBC Capital
$156.13
Hold
88.11%
Upside
Reiterated
07/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (NASDAQ: ALNY), Ultragenyx Pharmaceutical (NASDAQ: RARE) and Bausch Health Companies (NYSE: BHC)
Barclays Analyst forecast on MX:BHCN
Glen Santangelo
Barclays
Barclays
$121.43
Hold
46.30%
Upside
Assigned
06/03/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (NASDAQ: ABVX), Bausch Health Companies (NYSE: BHC) and Healthequity (NASDAQ: HQY)
Truist Financial Analyst forecast on MX:BHCN
Les Sulewski
Truist Financial
Truist Financial
―
Hold
―
Reiterated
05/01/26
Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (NYSE: BHC), Irhythm Technologies (NASDAQ: IRTC) and Bicycle Therapeutics (NASDAQ: BCYC)
Evercore ISI Analyst forecast on MX:BHCN
Umer Raffat
Evercore ISI
Evercore ISI
―
Hold
―
Reiterated
04/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (NYSE: TDOC), Bausch Health Companies (NYSE: BHC) and AbbVie (NYSE: ABBV)
TD Cowen Analyst forecast on MX:BHCN
Michael Nedelcovych
TD Cowen
TD Cowen
$121.43
Hold
46.30%
Upside
Reiterated
04/30/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Evolus (NASDAQ: EOLS) and Bausch Health Companies (NYSE: BHC)
Bank of America Securities Analyst forecast on MX:BHCN
Jason Gerberry
Bank of America Securities
Bank of America Securities
$86.74
Sell
4.50%
Upside
Reiterated
02/18/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (NYSE: MDT), Bausch Health Companies (NYSE: BHC) and Insulet (NASDAQ: PODD)
Raymond James Analyst forecast on MX:BHCN
Michael W. Freeman
Raymond James
Raymond James
$138.78
Hold
67.21%
Upside
Reiterated
08/05/25
Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (NYSE: BHC) and IDEAYA Biosciences (NASDAQ: IDYA)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
ZURAZura Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bausch Health Companies

3 Months
Jason GerberryBank of America Securities
Success Rate
6/13 ratings generated profit
46%
Average Return
-3.62%
Copying Jason Gerberry's trades and holding each position for 3 Months would result in 46.15% of your transactions generating a profit, with an average return of -3.62% per trade.
1 Year
Jason GerberryBank of America Securities
Success Rate
9/13 ratings generated profit
69%
Average Return
+10.62%
Copying Jason Gerberry's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +10.62% per trade.
2 Years
Jason GerberryBank of America Securities
Success Rate
11/13 ratings generated profit
85%
Average Return
+16.48%
Copying Jason Gerberry's trades and holding each position for 2 Years would result in 84.62% of your transactions generating a profit, with an average return of +16.48% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BHCN Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
8
5
6
4
3
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
5
6
4
3
In the current month, BHCN has received 0 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. BHCN average Analyst price target in the past 3 months is 138.78.
Each month's total comprises the sum of three months' worth of ratings.

BHCN Financial Forecast

BHCN Earnings Forecast

Next quarter’s earnings estimate for BHCN is $21.16 with a range of $16.96 to $23.15. The previous quarter’s EPS was $21.85. BHCN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year BHCN has Performed in-line its overall industry.
Next quarter’s earnings estimate for BHCN is $21.16 with a range of $16.96 to $23.15. The previous quarter’s EPS was $21.85. BHCN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year BHCN has Performed in-line its overall industry.

BHCN Sales Forecast

Next quarter’s sales forecast for BHCN is $46.75B with a range of $45.65B to $47.64B. The previous quarter’s sales results were $48.85B. BHCN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.23% of the time in the same period. In the last calendar year BHCN has Performed in-line its overall industry.
Next quarter’s sales forecast for BHCN is $46.75B with a range of $45.65B to $47.64B. The previous quarter’s sales results were $48.85B. BHCN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.23% of the time in the same period. In the last calendar year BHCN has Performed in-line its overall industry.

BHCN Stock Forecast FAQ

What is MX:BHCN’s average 12-month price target, according to analysts?
Based on analyst ratings, Bausch Health Companies’s 12-month average price target is 138.78.
    What is MX:BHCN’s upside potential, based on the analysts’ average price target?
    Bausch Health Companies has 67.21% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Bausch Health Companies a Buy, Sell or Hold?
          Bausch Health Companies has a consensus rating of Hold, which is based on 0 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Bausch Health Companies’s share price target?
            The average share price target for Bausch Health Companies is 138.78. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $156.13 ,and the lowest forecast is $121.43. The average share price target represents 67.21% Increase from the current price of $83.
              What do analysts say about Bausch Health Companies?
              Bausch Health Companies’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.
                How can I buy shares of Bausch Health Companies?
                To buy shares of MX:BHCN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.